SBMU, Pharmaceutical Research Sciences
  • Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About
    • Aim and Scope
    • Ownership & Management
    • Indexing
    • Editorial Team
  • New Submission
  • Author Guidelines
    • Guideline
    • Types of articles
    • Templates
    • Publication Fees
  • Policies and Process
    • Publication Policy
    • Peer Review Process
    • Open Access Policy
    • plagiarism
    • Archiving
    • Privacy Statement
    • Copyright Notice
    • Waiver policy
    • Complaints Policy
    • Post- Publication Discussions and Corrections Policy
    • Advertisement and Marketing
  • Issues
    • Current
    • Archives
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 1 No. 1 (2018): Pharmacy Updates 2018 (Congress Proceeding)
  4. Supplementary Issues: Reviews of books, journal, congress, other media Special issues, and Scientific news

Vol. 1 No. 1 (2018)

March 2018

Protective effect of Harmine on kidney disorders induced by nicotine in male mice

  • Faramarz Jalili
  • Cyrus Jalili

International Pharmacy Acta, Vol. 1 No. 1 (2018), 4 March 2018 , Page 132-133
https://doi.org/10.22037/ipa.v1i1.20025 Published: 2018-03-04

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction: Harmine is one of the Harmal-deived alkaloids with anti-proliferatory effect on cell lines. Nicotine is a major toxic component of cigarette smoke and it is a major risk factor in the development of functional disorder of several organ systems. Nicotine from tobacco products is absorbed into the blood across the lungs,  nasal and buccal mucosa. The current study aimed to investigate the effect of Harmine and Nicotine on the weight of kidney and number of glumeruli and glomerular diameter, kidney tissue and serum levels of nitric oxide, BUN, Creatinine and TAC in mice.

Methods and Results: In this study, 48 male Mice were divided in to 8 groups: control, nicotine–treated group (2.5 mg/kg/day); harmine-treated groups (5,10, 15 mg/kg./day); and nicotine and harmine treated group intraperitoneal administration for successive 14 days. These mice were randomly assigned to 8 groups(n=6). After 24 hours animal were killed , the kidney was sampled: tissue sections were prepared and examined by light microscope. weight of kidney  and number of glumeruli and glomerular diameter and serum levels of nitric oxide, BUN, Creatinine and TAC (Total antioxidant capacity) were analyzed (one-way ANOVA). Then data were P<0.05 was considered significant. The results indicate that nicotine administration significantly increased BUN, creatinine and nitric oxide levels compared to saline group (P<0/05). Harmine   (10, 15 mg/kg./day) significantly decreased BUN, creatinine and nitric oxide levels  compared to control group and nicotine group (p<0.05). Nicotine treatment significantly increased glomerular diameter compared to control group (p<0.05). as well as, nicotine administration significantly decreased TAC levels compared to saline group (P<0/05). Histopathology of the kidney confirmed the changes induced by nicotine and the renal protection effect of harmine.

Conclusions: It seems that harmine administration could improve kidney changes and prevented nicotine-induced adverse effects on serum levels of nitric oxide, BUN and Creatinine and Total antioxidant capacity.

Keywords:
  • Harmine, Nicotine, nitric oxide, mice
  • PDF

How to Cite

Jalili, F., & Jalili, C. (2018). Protective effect of Harmine on kidney disorders induced by nicotine in male mice. International Pharmacy Acta, 1(1), 132–133. https://doi.org/10.22037/ipa.v1i1.20025
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 262 times
  • PDF Downloaded: 168 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors
  • For Librarians

Make a Submission

Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

Powered by OJSPlus